Salidroside alleviates doxorubicin-induced hepatotoxicity via Sestrin2/AMPK-mediated pyroptotic inhibition
Food and Chemical Toxicology · 2025-05 · 199 · 115335
DOI: 10.1016/j.fct.2025.115335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2025-05. Verfasst von Nan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine, Integrative Science Center of Germplasm Creation in Western China (…. Hauptthemen laut MEDLINE: Glucosides, Doxorubicin, Phenols, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin (DOX) is a potent anticancer drug, while its toxic side effects involve multi-organ toxicity, including hepatotoxicity. This study aims to investigate the therapeutic potential of salidroside against DOX-induced hepatotoxicity and elucidate its underlying mechanisms. Result showed that salidroside exhibited a liver protective effect in DOX-induced hepatotoxicity in mice, represented by the decreased serum ALT, AST and LDH levels, as well as the rescue of pathological changes in mice livers. Further study showed salidroside reduced the expression level of pyroptosis-associated proteins, including NLRP3, cleaved-caspase 1, gasdermin D (GSDMD-N) and mature IL-1β in mice liver tissues. In vitro study confirmed salidroside exerted a similar effect in AML12 cells. Mechanistically, salidroside alleviated mitochondrial dysfunction by activating the PGC-1α/Mfn2 signaling pathway, and restrained the endoplasmic reticulum (ER) stress, represented by the downregulation of GRP78 and p-PERK/PERK level. Subsequent investigations revealed that salidroside activated the Sestrin2/AMPK pathway, while the application of AMPK inhibitors, PGC-1α siRNA or Sestrain2 siRNA reversed the effects of salidroside on ameliorating mitochondrial dysfunction and ER stress, suggesting salidroside could be a promising therapeutic strategy for alleviating DOX-induced hepatotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Key Laboratory of New Drug Screening from Traditional Chinese Medicine, Integrative Science Center of Germplasm Creation in Western China (Chongqing) Science City & Southwest University, SWU-TAAHC Medicinal Pl…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, N., Gao, Z., Zhan, H., Jing, L., Meng, F., & Chen, M. (2025). Salidroside alleviates doxorubicin-induced hepatotoxicity via Sestrin2/AMPK-mediated pyroptotic inhibition. Food and Chemical Toxicology, 199, 115335. https://doi.org/10.1016/j.fct.2025.115335
Vancouver
Wang N, Gao Z, Zhan H, Jing L, Meng F, Chen M. Salidroside alleviates doxorubicin-induced hepatotoxicity via Sestrin2/AMPK-mediated pyroptotic inhibition. Food and Chemical Toxicology. 2025;199:115335. doi:10.1016/j.fct.2025.115335
BibTeX
@article{Wang2025,
author = {Wang, Nan and Gao, Zhengshan and Zhan, Honghong and Jing, Lin and Meng, Fancheng and Chen, Min},
title = {Salidroside alleviates doxorubicin-induced hepatotoxicity via Sestrin2/AMPK-mediated pyroptotic inhibition},
journal = {Food and Chemical Toxicology},
year = {2025},
volume = {199},
pages = {115335},
doi = {10.1016/j.fct.2025.115335}
}
EUVIMED